Back
Perspective Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.34
Seasonality Move:
26.28%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is relatively stagnant and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.9 | Buy |
| 20-day SMA: | 12.33 | Buy |
| 50-day SMA: | 13.38 | Sell |
| 200-day SMA: | 12.62 | Sell |
| 8-day EMA: | 12.07 | Buy |
| 20-day EMA: | 12.31 | Buy |
| 50-day EMA: | 12.82 | Sell |
| 200-day EMA: | 11.77 | Buy |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 48.71 | Sell |
| Chaikin Money Flow: | 329079 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.9 - 13.06) | Sell |
| Bollinger Bands (100): | (11.22 - 14.34) | Sell |
Perspective Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 12.34 while CATX 8-day simple moving average is 11.90, which is a Buy signal.
- The stock price of CATX is 12.34 while Perspective Therapeutics 20-day SMA is 12.33, which makes it a Buy.
- Perspective Therapeutics 50-day simple moving average is 13.38 while CATX share price is 12.34, making it a Sell technically.
- CATX stock price is 12.34 and Perspective Therapeutics 200-day simple moving average is 12.62, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $12.34. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
832.06M
Price in USD:
12.34
Share Volume:
425.87K
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.20
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 12.34 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 12.34 while CATX 8-day exponential moving average is 12.07, which is a Buy signal.
- The stock price of CATX is 12.34 while Perspective Therapeutics 20-day EMA is 12.31, which makes it a Buy.
- Perspective Therapeutics 50-day exponential moving average is 12.82 while CATX share price is 12.34, making it a Sell technically.
- CATX stock price is 12.34 and Perspective Therapeutics 200-day simple moving average is 11.77, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is -0.33, suggesting Perspective Therapeutics is a Sell
- Perspective Therapeutics Relative Strength Index (RSI) is 48.71, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (11.9 - 13.06), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (11.22 - 14.34), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.